{"id":"tp-56806","type":"article-newspaper","title":"Tandem Diabetes Care Shares Rise 12% After Tubeless Mobi Clearance","author":"Riza Dagoc","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/regulation/56806","datePublished":"2026-11-13T15:04:43.000Z","dateModified":"2026-11-13T15:04:43.000Z","language":"en","abstract":"Tandem said the U.S. Food and Drug Administration granted 510(k) clearance for the tubeless system. Shares reached $19.62 at 9:59 a.m. ET.","section":"Regulation","references":[]}